39 medicines added to list of essentials, prices to come down

NEW DELHI: In a move that may bring down prices of some widely used essential drugs, the government has revised the National List of Essential Medicines, adding 39 new ones under the list for proposed price cap, a source said. Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

The government has also deleted 16 drugs from the existing list and the final NLEM 2021 now contains 399 essential medicines, up from 376 drugs that are currently under direct price control.

The revised list, prepared by an expert committee under the Indian Council of Medical Research, was submitted to health minister Mansukh Mandaviya on Thursday. Once the list is notified by the health ministry, it will be evaluated by the Standing Committee on Affordable Medicines and Health Products (SCAMHP) to assess which of the medicines require price capping.

The final price capping will be done by the National Pharmaceutical Pricing Authority based on the recommendations of the SCAMHP, headed by Niti Aayog member-health Dr V K Paul.

Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states